Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition.
Cheng
Yan
Y
Department of Pharmacology and The Penn State Cancer Institute, The Pennsylvania State University College of Medicine, and Milton S Hershey Medical Center, Hershey, Pennsylvania, United States of America.
Li
Huaijun
H
Ren
Xingcong
X
Niu
Tingkuang
T
Hait
William N
WN
Yang
Jinming
J
D000263:Adenylate Kinase / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology; D001343:Autophagy; D001943:Breast Neoplasms / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D045744:Cell Line, Tumor; D054736:Elongation Factor 2 Kinase / Q000235:genetics* / Q000502:physiology; D005260:Female; D000077156:Gefitinib; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D000077341:Lapatinib; D011799:Quinazolines / Q000494:pharmacology; D015398:Signal Transduction; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D036341:Intercellular Signaling Peptides and Proteins; D011799:Quinazolines; D000077341:Lapatinib; D054736:Elongation Factor 2 Kinase; D000263:Adenylate Kinase; D000068878:Trastuzumab; D000077156:Gefitinib; D002118:Calcium